For Dexcom stock forecast 2025, competitive advantage stems from proprietary sensor technology and subscription-based revenue streams, which may secure double-digit valuation multiples. We recently published a list of the 10 Best Medical Device Stocks To Buy According to Hedge Funds . In this article, we are going to take a look at where DexCom, Inc. (NASDAQ: DXCM ) stands against other best medical device stocks to buy right now. Adjusted gross profit totaled $695.9 million, up 9.1% from the prior-year quarter’s level. DexCom reported an adjusted gross margin (as a percentage of revenues) of 60.1%, down 340 basis points year over year. Options market pricing for Dexcom stock forecast 2025 shows elevated call volume, indicating traders are positioning for an upward price swing in mid-